In leukemia, a previous study reported that fasting could slow the progression of acute lymphoblastic leukemia (ALL) but not acute myeloid leukemia (AML) by activating the protein PR/SET domain 1 (PRDM1)-mediated leptin receptor and downstream signaling [167]. Here, PRDM1 is linked to acute myeloid leukemia.